Sight Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Sight Sciences's estimated annual revenue is currently $43.3M per year.
- Sight Sciences received $10.0M in venture funding in October 2017.
- Sight Sciences's estimated revenue per employee is $166,385
- Sight Sciences's total funding is $108.7M.
- Sight Sciences's current valuation is $751.2M. (January 2022)
Employee Data
- Sight Sciences has 260 Employees.
- Sight Sciences grew their employee count by 0% last year.
Sight Sciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Founder and CTO | Reveal Email/Phone |
3 | VP - Pipeline Strategy and Corporate/Surgical Marketing | Reveal Email/Phone |
4 | VP, IT | Reveal Email/Phone |
5 | VP, Pharma Research and Development | Reveal Email/Phone |
6 | VP Regulatory Affairs | Reveal Email/Phone |
7 | VP Business Operations | Reveal Email/Phone |
8 | VP OPS & Manufacturing Engineering | Reveal Email/Phone |
9 | VP Sales - US Surgical | Reveal Email/Phone |
10 | vice president global market access | Reveal Email/Phone |
Sight Sciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Sight Sciences?
Sight Sciences, Inc. is a medical devices company based out of Menlo Park, California, United States.
keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals
$108.7M
Total Funding
260
Number of Employees
$43.3M
Revenue (est)
0%
Employee Growth %
$751.2M
Valuation
N/A
Accelerator
Sight Sciences News
Sight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and...
Sight Sciences aims to transform ophthalmology and optometry through its proprietary devices which targets the underlying cause of prevalent eye...
Buoyed by tens of millions in new revenue and a successful IPO that brought in proceeds of more than a quarter-billion dollars, Sight Sciences is scoping...
MENLO PARK, Calif., March 4, 2021 /PRNewswire/ -- Sight Sciences, Inc., a growth-stage medical device company focused on addressing the underlying causes of the world's most prevalent eye conditions, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the OMNI® Surgical ...
MENLO PARK, Calif., Dec. 1, 2020 /PRNewswire/ -- Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced the closing of its Series F Preferred Stock financing led by ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $750M | 274 | 5% | N/A |
#2 | $0.4M | 275 | 10% | $236.7M |
#3 | $15M | 280 | 21% | N/A |
#4 | $89.3M | 280 | 9% | N/A |
#5 | $15M | 282 | 37% | N/A |
Sight Sciences Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2016-03-16 | $7.0M | B | Hicks Equity Partners | Article |
| 2017-10-10 | $10.0M | C | Allegro Investment Fund | Article |